Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study
Identifieur interne : 000547 ( Main/Exploration ); précédent : 000546; suivant : 000548Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study
Auteurs : Hanne Madsen [Danemark] ; Kim Brixen [Danemark] ; Jesper Hallas [Danemark]Source :
- The Clinical Respiratory Journal [ 1752-6981 ] ; 2010-01.
English descriptors
- KwdEn :
Abstract
Introduction: A common extrapulmonary effect to chronic obstructive pulmonary disease (COPD) is osteoporosis. Objectives: To characterise the diagnostic activity regarding osteoporosis [i.e. the use of dual‐energy X‐ray absorptiometry (DXA)] and the pattern of applied pharmacological intervention to prevent fractures in COPD patients in relation to the use of prednisolone. Methods: This study was a register study covering the residents of the Danish County of Funen linking data from Odense Pharmacoepidemiologic Database (OPED), a DXA‐database and Funen Patient Administrative System, a database with data on hospitals admissions. OPED has complete capture of fulfilled prescriptions. We identified 1909 COPD patients admitted with a main diagnosis of COPD. Using OPED we extracted prescriptions for prednisolone and antiresorptive medicine from these COPD patients for the year 2004. Results: COPD patients who had filled a prescription for prednisolone (P‐COPD) were DXA‐scanned more frequently (17%) than those who had not (non‐P‐COPD) (9%) and were prescribed antiresorptive medicine more often (27%) than non‐P‐COPD (16%). In both groups 94% were either osteopenic or osteoporotic. Logistic regression models predicted that DXA‐scans were offered to women, to the young, to the recipients of high systemic steroid doses and to those with frequent admission for COPD. Given an osteoporosis diagnosis, treatment was offered to those with high steroid doses and those with frequent admissions for COPD. Conclusion: DXA are underutilised compared with the high frequency of osteoporosis or osteopenia in DXA‐scanned hospitalised COPD patients, especially in elderly. Guidelines concerning screening, prevention and treatment of osteoporosis in COPD patients with or without glucocorticoid treatment are needed. Please cite this paper as: Madsen H, Brixen K and Hallas J. Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study. The Clinical Respiratory Journal 2009; DOI:10.1111/j.1752‐699X.2009.00138.x.
Url:
DOI: 10.1111/j.1752-699X.2009.00138.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study</title><author><name sortKey="Madsen, Hanne" sort="Madsen, Hanne" uniqKey="Madsen H" first="Hanne" last="Madsen">Hanne Madsen</name></author><author><name sortKey="Brixen, Kim" sort="Brixen, Kim" uniqKey="Brixen K" first="Kim" last="Brixen">Kim Brixen</name></author><author><name sortKey="Hallas, Jesper" sort="Hallas, Jesper" uniqKey="Hallas J" first="Jesper" last="Hallas">Jesper Hallas</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CA005AB2B1B123B61CD6FB63BBA7355643158BAE</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1111/j.1752-699X.2009.00138.x</idno><idno type="url">https://api.istex.fr/document/CA005AB2B1B123B61CD6FB63BBA7355643158BAE/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002F73</idno><idno type="wicri:Area/Main/Curation">002B83</idno><idno type="wicri:Area/Main/Exploration">000547</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study</title><author><name sortKey="Madsen, Hanne" sort="Madsen, Hanne" uniqKey="Madsen H" first="Hanne" last="Madsen">Hanne Madsen</name><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Clinical Pharmacology, University of Southern Denmark, Odense C</wicri:regionArea><wicri:noRegion>Odense C</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Respiratory Medicine, Odense University Hospital, Odense C</wicri:regionArea><wicri:noRegion>Odense C</wicri:noRegion></affiliation></author><author><name sortKey="Brixen, Kim" sort="Brixen, Kim" uniqKey="Brixen K" first="Kim" last="Brixen">Kim Brixen</name><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Endocrinology, Odense University Hospital, Odense C</wicri:regionArea><wicri:noRegion>Odense C</wicri:noRegion></affiliation></author><author><name sortKey="Hallas, Jesper" sort="Hallas, Jesper" uniqKey="Hallas J" first="Jesper" last="Hallas">Jesper Hallas</name><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Clinical Pharmacology, University of Southern Denmark, Odense C</wicri:regionArea><wicri:noRegion>Odense C</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">The Clinical Respiratory Journal</title><idno type="ISSN">1752-6981</idno><idno type="eISSN">1752-699X</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-01">2010-01</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="22">22</biblScope><biblScope unit="page" to="29">29</biblScope></imprint><idno type="ISSN">1752-6981</idno></series><idno type="istex">CA005AB2B1B123B61CD6FB63BBA7355643158BAE</idno><idno type="DOI">10.1111/j.1752-699X.2009.00138.x</idno><idno type="ArticleID">CRJ138</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1752-6981</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>bone density conservation agents</term><term>glucocorticoids</term><term>osteoporosis</term><term>pulmonary disease, chronic obstructive</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Introduction: A common extrapulmonary effect to chronic obstructive pulmonary disease (COPD) is osteoporosis. Objectives: To characterise the diagnostic activity regarding osteoporosis [i.e. the use of dual‐energy X‐ray absorptiometry (DXA)] and the pattern of applied pharmacological intervention to prevent fractures in COPD patients in relation to the use of prednisolone. Methods: This study was a register study covering the residents of the Danish County of Funen linking data from Odense Pharmacoepidemiologic Database (OPED), a DXA‐database and Funen Patient Administrative System, a database with data on hospitals admissions. OPED has complete capture of fulfilled prescriptions. We identified 1909 COPD patients admitted with a main diagnosis of COPD. Using OPED we extracted prescriptions for prednisolone and antiresorptive medicine from these COPD patients for the year 2004. Results: COPD patients who had filled a prescription for prednisolone (P‐COPD) were DXA‐scanned more frequently (17%) than those who had not (non‐P‐COPD) (9%) and were prescribed antiresorptive medicine more often (27%) than non‐P‐COPD (16%). In both groups 94% were either osteopenic or osteoporotic. Logistic regression models predicted that DXA‐scans were offered to women, to the young, to the recipients of high systemic steroid doses and to those with frequent admission for COPD. Given an osteoporosis diagnosis, treatment was offered to those with high steroid doses and those with frequent admissions for COPD. Conclusion: DXA are underutilised compared with the high frequency of osteoporosis or osteopenia in DXA‐scanned hospitalised COPD patients, especially in elderly. Guidelines concerning screening, prevention and treatment of osteoporosis in COPD patients with or without glucocorticoid treatment are needed. Please cite this paper as: Madsen H, Brixen K and Hallas J. Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study. The Clinical Respiratory Journal 2009; DOI:10.1111/j.1752‐699X.2009.00138.x.</div></front></TEI><affiliations><list><country><li>Danemark</li></country></list><tree><country name="Danemark"><noRegion><name sortKey="Madsen, Hanne" sort="Madsen, Hanne" uniqKey="Madsen H" first="Hanne" last="Madsen">Hanne Madsen</name></noRegion><name sortKey="Brixen, Kim" sort="Brixen, Kim" uniqKey="Brixen K" first="Kim" last="Brixen">Kim Brixen</name><name sortKey="Hallas, Jesper" sort="Hallas, Jesper" uniqKey="Hallas J" first="Jesper" last="Hallas">Jesper Hallas</name><name sortKey="Madsen, Hanne" sort="Madsen, Hanne" uniqKey="Madsen H" first="Hanne" last="Madsen">Hanne Madsen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000547 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000547 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:CA005AB2B1B123B61CD6FB63BBA7355643158BAE
|texte= Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study
}}
| This area was generated with Dilib version V0.6.23. |  |